News
7h
Rest of World on MSNChina’s AI drug discovery companies land huge deals with Big PharmaAI research is central to many of the deals. In April, French pharmaceutical giant Sanofi announced a $1.7 billion agreement ...
USA-based Madrigal Pharmaceuticals today announced that it has entered into an exclusive global license agreement with CSPC ...
The idea is that SYH2086 can be paired with Rezdiffra, a selective thyroid hormone receptor agonist that became the first FDA-approved drug for metabolic dysfunction-associated steatohepatitis (MASH) ...
Madrigal Pharmaceuticals said on Wednesday it has entered into a licensing agreement worth up to $2 billion with China's CSPC Pharmaceutical Group to develop an oral GLP-1 drug for a serious form of ...
The pharma sees the drug, gefurulimab, as a more convenient, self-administered alternative to the infused medicines it sells ...
DelveInsight’s Advanced Ovarian Cancer pipeline report depicts a robust space with 50+ active players working to develop 50+ ...
International firms are also looking to partner with Chinese counterparts at earlier stages to co-develop drugs – such as ...
AstraZeneca, a pharmaceutical company, has announced its plans to bring a drug substance manufacturing facility to Virginia.
AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of manufacturing and R&D projects planned over the next five years.
British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump administration claiming some credit due to its tariff policy and Presiden… ...
In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to build its largest drug manufacturing facility in the world somewhere in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results